-
D-N-Acetylgalactosamine Workflow and QC Guide
2026-09-11
D-N-Acetylgalactosamine (SKU B7904) provides a defined, high-purity reagent for glycoprotein, brain heteropolysaccharide, and glycosylation-related workflows. It is suitable for aqueous or compatible DMSO preparations, but it should not be used in ethanol-based methods or retained as a long-term solution.
-
α-Bungarotoxin: Reliable Nicotinic Receptor Blockade
2026-09-10
This scenario-driven guide shows how α-Bungarotoxin (SKU B6950) can strengthen mechanistic interpretation in viability, proliferation, cytotoxicity, and cholinergic signaling assays. It links receptor pharmacology with practical design, storage, optimization, vendor evaluation, and evidence from a 2026 placental necroptosis study.
-
GANT61 Workflows for GLI-Driven Cancer Research
2026-09-10
GANT61 is a practical GLI inhibitor for separating Hedgehog-pathway dependence from nonspecific cytotoxicity in cell, co-culture, and xenograft studies. This workflow-focused guide covers solvent handling, dose-response design, immune-evasion assays, and troubleshooting for more reproducible cancer research.
-
HyperScribe T7 High Yield Cy3 RNA Labeling Kit
2026-09-09
Build fluorescent RNA probes for in situ hybridization and Northern blot workflows while balancing transcription yield against Cy3 signal density. The HyperScribe T7 High Yield Cy3 RNA Labeling Kit also supports assay development around RNA localization, probe specificity, and delivery-oriented research.
-
Syringin Natural Product for RCC Assay Design
2026-09-09
Build a practical renal cell carcinoma workflow around Syringin, combining viability, migration, apoptosis, and EGFR/PI3K/Akt measurements with sunitinib-sensitization studies. The guide emphasizes compound handling, orthogonal validation, dose-matrix design, and troubleshooting so natural product research produces interpretable mechanistic data.
-
Rational Design of NIR-II Liposomes for Intravital Imaging
2026-09-08
Yu and colleagues developed an IR-1061 liposomal nanosystem by systematically examining phospholipid charge and fluorophore loading. Their results show that anionic liposomes improve encapsulation, whereas excessive IR-1061 promotes aggregation and weakens fluorescence, enabling a formulation with high vascular contrast and persistent imaging over more than 16 hours in mice.
-
BIBR 1532 Telomerase Inhibitor Workflows
2026-09-08
Build a time-resolved telomerase inhibition workflow with BIBR 1532, linking hTERT suppression to proliferation, apoptosis, and telomere phenotypes. The guide also shows how to adapt findings from CF10–EdU research without confusing DNA damage with direct telomerase inhibition.
-
RNA Pol II Inhibition and Active Cell Death
2026-09-07
Harper et al. show that RNA polymerase II inhibition can activate apoptosis through loss of hypophosphorylated RNA Pol IIA, rather than through transcriptional failure alone. Their functional-genomic and chemogenetic analyses define a Pol II degradation-dependent apoptotic response that may help explain the activity of several otherwise unrelated anticancer drugs.
-
AP20187: From Dimerization to Assay Design
2026-09-05
AP20187 is a chemical inducer of dimerization that converts engineered proximity into controllable cellular signaling. This article focuses on assay architecture, decision points, and lessons from 14-3-3 research rather than repeating a conventional product overview.
-
Br-DAPI Workflows for Cardiac DNA Imaging
2026-09-05
Br-DAPI converts nuclear DNA into a sensitive, membrane-permeable readout for live-cell screening and fixed-cell endpoint imaging. This practical workflow shows how to pair a DAPI fluorescent dye with palmitate injury, ER-stress, viability, and apoptosis assays without mistaking DNA fluorescence for mechanistic proof.
-
Sodium Picosulfate in Gut–Brain Research
2026-09-04
Sodium Picosulfate gives researchers a chemically defined way to model intestinal water and electrolyte handling, stool output, and constipation-related phenotypes. This workflow guide shows how to connect those endpoints with liver-cell assays, microbiota sampling, and exploratory neuroinflammation imaging without overstating translational evidence.
-
ABT-737 and the Mitochondrial Logic of Cell Death
2026-09-04
ABT-737 offers translational researchers a defined way to interrogate BCL-2 family dependence, while emerging RNA Pol II biology reveals a complementary route by which nuclear stress can activate mitochondrial apoptosis. Together, these insights support more rigorous mechanism-first study design across hematologic and solid-tumor models.
-
Berberrubine Chloride: Mechanism to Assay Design
2026-09-03
Berberrubine chloride is a multi-target isoquinoline alkaloid for cancer, inflammatory, glucose, and urate research. This guide focuses on the underexplored link between chemical identity, derivative evidence, target biology, and assay design.
-
Alcian Blue & Nuclear Fast Red Staining Kit
2026-09-03
The Alcian Blue & Nuclear Fast Red Staining Kit provides a pH 2.5 dual-stain strategy for acid mucin detection and chondrogenic differentiation staining. This guide explains how to separate true biological signal from specimen visibility, an important distinction for mesenchymal stem cell assays and tissue histology.
-
Alpha-Ketoglutarate Workflows for Tumor Metabolism
2026-09-02
Build controlled α-KGA exposure, co-culture, and enzyme assays around a metabolite that connects mitochondrial carbon flux with immune signaling. This practical workflow translates cholangiocarcinoma findings into reproducible metabolic reprogramming research while separating mechanistic evidence from exploratory dosing.